Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Coronary Heart Disease | Research

Association between admission heart rate and in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: a retrospective cohort study

Authors: Ruoqing Zhou, Dianzhu Pan

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Background

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) combined with respiratory failure (RF) is a chronic respiratory disease that seriously endangers human health. This study aimed to specifically evaluate the relationship between admission heart rate (AHR) and in-hospital mortality in patients with combined AECOPD and RF to better inform clinical treatment.

Methods

This retrospective cohort study included 397 patients admitted to a Chinese hospital between January 2021 and March 2023. The primary outcome measure was all-cause in-hospital mortality. Multivariate logistic regression analyses were performed to calculate adjusted hazard ratios (OR) with corresponding 95% confidence intervals (CI), and curve fitting and threshold effect were performed to address nonlinear relationships.

Results

In total, 397 patients with AECOPD/RF were screened. The mean (± SD) age of the study cohort was 72.6 ± 9.5 years, approximately 49.4% was female, and the overall in-hospital mortality rate was 5%. Multivariate logistic regression analysis and smooth curve fitting revealed a nonlinear association between AHR and in-hospital mortality in the study population, with 100 beats/min representing the inflection point. Left of the inflection point, the effect size (OR) was 0.474 (95% CI 0.016 ~ 13.683; p = 0.6635). On the right side, each 1 beat/min increase in AHR resulted in an effect size (OR) of 1.094 (95% CI 1.01 ~ 1.186; p = 0.0281).

Conclusions

Results of the present study demonstrated a nonlinear relationship between AHR and in-hospital mortality in patients with AECOPD/RF. When AHR was < 100 beats/min, it was not statistically significant; however, AHR > 100 beats/min was a predictor of potential mortality, which increased by 9.4% for every 1 beat/min increase in AHR.
Literature
1.
go back to reference Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, Montes DOM, Papi A, Sin DD, Han MK, et al. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. Am J Resp Crit Care. 2022;206(11):1317–25.CrossRef Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, Montes DOM, Papi A, Sin DD, Han MK, et al. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. Am J Resp Crit Care. 2022;206(11):1317–25.CrossRef
2.
go back to reference Agusti A, Melen E, DeMeo DL, Breyer-Kohansal R, Faner R. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Resp Med. 2022;10(5):512–24.CrossRef Agusti A, Melen E, DeMeo DL, Breyer-Kohansal R, Faner R. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Resp Med. 2022;10(5):512–24.CrossRef
3.
go back to reference Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin D, Han M, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin D, Han M, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164.
4.
go back to reference Celli BR, Fabbri LM, Aaron SD, Agusti A, Brook R, Criner GJ, Franssen F, Humbert M, Hurst JR, O’Donnell D, et al. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal. Am J Resp Crit Care. 2021;204(11):1251–8.CrossRef Celli BR, Fabbri LM, Aaron SD, Agusti A, Brook R, Criner GJ, Franssen F, Humbert M, Hurst JR, O’Donnell D, et al. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal. Am J Resp Crit Care. 2021;204(11):1251–8.CrossRef
5.
go back to reference Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Resp Crit Care. 2013;187(4):347–65.CrossRef Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Resp Crit Care. 2013;187(4):347–65.CrossRef
7.
go back to reference Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–63.PubMedCrossRef Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–63.PubMedCrossRef
8.
go back to reference Alapati V, Tang F, Charlap E, Chan PS, Heidenreich PA, Jones PG, Spertus JA, Srinivas V, Kizer JR. Discharge Heart Rate After Hospitalization for Myocardial Infarction and Long-Term Mortality in 2 US Registries. J Am Heart Assoc. 2019;8(3): e10855.CrossRef Alapati V, Tang F, Charlap E, Chan PS, Heidenreich PA, Jones PG, Spertus JA, Srinivas V, Kizer JR. Discharge Heart Rate After Hospitalization for Myocardial Infarction and Long-Term Mortality in 2 US Registries. J Am Heart Assoc. 2019;8(3): e10855.CrossRef
9.
go back to reference Kovar D, Cannon CP, Bentley JH, Charlesworth A, Rogers WJ. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? Clin Cardiol. 2004;27(2):80–6.PubMedCrossRef Kovar D, Cannon CP, Bentley JH, Charlesworth A, Rogers WJ. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? Clin Cardiol. 2004;27(2):80–6.PubMedCrossRef
10.
go back to reference Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, Ross JJ. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol. 1990;65(9):547–53.PubMedCrossRef Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, Ross JJ. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol. 1990;65(9):547–53.PubMedCrossRef
11.
go back to reference Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, et al. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. J Gen Intern Med. 2008;23(3):310–6.PubMedPubMedCentralCrossRef Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, et al. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. J Gen Intern Med. 2008;23(3):310–6.PubMedPubMedCentralCrossRef
12.
go back to reference Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, Akkerhuis KM, Harrington RA, Deckers JW, Armstrong PW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000;101(22):2557–67.PubMedCrossRef Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, Akkerhuis KM, Harrington RA, Deckers JW, Armstrong PW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000;101(22):2557–67.PubMedCrossRef
13.
go back to reference Henning H, Gilpin EA, Covell JW, Swan EA, O’Rourke RA, Ross JJ. Prognosis after acute myocardial infarction: a multivariate analysis of mortality and survival. Circulation. 1979;59(6):1124–36.PubMedCrossRef Henning H, Gilpin EA, Covell JW, Swan EA, O’Rourke RA, Ross JJ. Prognosis after acute myocardial infarction: a multivariate analysis of mortality and survival. Circulation. 1979;59(6):1124–36.PubMedCrossRef
14.
go back to reference Disegni E, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Zion M, Boyko V, Behar S. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol. 1995;48(10):1197–205.PubMedCrossRef Disegni E, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Zion M, Boyko V, Behar S. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol. 1995;48(10):1197–205.PubMedCrossRef
15.
go back to reference Rothnie KJ, Smeeth L, Herrett E, Pearce N, Hemingway H, Wedzicha J, Timmis A, Quint JK. Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease. Heart. 2015;101(14):1103–10.PubMedCrossRef Rothnie KJ, Smeeth L, Herrett E, Pearce N, Hemingway H, Wedzicha J, Timmis A, Quint JK. Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease. Heart. 2015;101(14):1103–10.PubMedCrossRef
16.
go back to reference Rothnie KJ, Yan R, Smeeth L, Quint JK. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 2015;5(9):e7824.CrossRef Rothnie KJ, Yan R, Smeeth L, Quint JK. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 2015;5(9):e7824.CrossRef
17.
go back to reference Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. EUR RESPIR J. 2003;22(5):809–14.PubMedCrossRef Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. EUR RESPIR J. 2003;22(5):809–14.PubMedCrossRef
18.
go back to reference Byrd JB, Newby DE, Anderson JA, Calverley P, Celli BR, Cowans NJ, Crim C, Martinez FJ, Vestbo J, Yates J, et al. Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial. Eur Heart J. 2018;39(33):3128–34.PubMedPubMedCentralCrossRef Byrd JB, Newby DE, Anderson JA, Calverley P, Celli BR, Cowans NJ, Crim C, Martinez FJ, Vestbo J, Yates J, et al. Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial. Eur Heart J. 2018;39(33):3128–34.PubMedPubMedCentralCrossRef
19.
go back to reference Yang Q, Zheng J, Chen W, Chen X, Wen D, Chen W, Xiong X, Zhang Z. Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study. Front Med-Lausanne. 2021;8:640785.PubMedPubMedCentralCrossRef Yang Q, Zheng J, Chen W, Chen X, Wen D, Chen W, Xiong X, Zhang Z. Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study. Front Med-Lausanne. 2021;8:640785.PubMedPubMedCentralCrossRef
20.
go back to reference Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens. 2004;26(7–8):637–44.PubMedCrossRef Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens. 2004;26(7–8):637–44.PubMedCrossRef
21.
go back to reference Palatini P, Benetos A, Julius S. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs. 2006;66(2):133–44.PubMedCrossRef Palatini P, Benetos A, Julius S. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs. 2006;66(2):133–44.PubMedCrossRef
22.
go back to reference Yang LT, Pellikka PA, Enriquez-Sarano M, Scott CG, Padang R, Mankad SV, Schaff HV, Michelena HI. Diastolic Blood Pressure and Heart Rate Are Independently Associated With Mortality in Chronic Aortic Regurgitation. J Am Coll Cardiol. 2020;75(1):29–39.PubMedCrossRef Yang LT, Pellikka PA, Enriquez-Sarano M, Scott CG, Padang R, Mankad SV, Schaff HV, Michelena HI. Diastolic Blood Pressure and Heart Rate Are Independently Associated With Mortality in Chronic Aortic Regurgitation. J Am Coll Cardiol. 2020;75(1):29–39.PubMedCrossRef
23.
go back to reference Antoni ML, Boden H, Delgado V, Boersma E, Fox K, Schalij MJ, Bax JJ. Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J. 2012;33(1):96–102.PubMedCrossRef Antoni ML, Boden H, Delgado V, Boersma E, Fox K, Schalij MJ, Bax JJ. Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J. 2012;33(1):96–102.PubMedCrossRef
24.
go back to reference Hsia J, Larson JC, Ockene JK, Sarto GE, Allison MA, Hendrix SL, Robinson JG, LaCroix AZ, Manson JE. Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ-Brit Med J. 2009;338:b219.CrossRef Hsia J, Larson JC, Ockene JK, Sarto GE, Allison MA, Hendrix SL, Robinson JG, LaCroix AZ, Manson JE. Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ-Brit Med J. 2009;338:b219.CrossRef
25.
go back to reference Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo A, Roe MT, Hong MK, Peterson ED. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. Eur Heart J. 2010;31(5):552–60.PubMedCrossRef Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo A, Roe MT, Hong MK, Peterson ED. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. Eur Heart J. 2010;31(5):552–60.PubMedCrossRef
26.
go back to reference Jang SY, Seon JY, Eun BL, Koh SB, Yoo JH, Lee WY, Yum HK, Yoon SJ, Oh IH, Bae SC, et al. Risk Factors of Outcomes of COVID-19 Patients in Korea: Focus on Early Symptoms. J Korean Med Sci. 2021;36(18):e132.PubMedPubMedCentralCrossRef Jang SY, Seon JY, Eun BL, Koh SB, Yoo JH, Lee WY, Yum HK, Yoon SJ, Oh IH, Bae SC, et al. Risk Factors of Outcomes of COVID-19 Patients in Korea: Focus on Early Symptoms. J Korean Med Sci. 2021;36(18):e132.PubMedPubMedCentralCrossRef
27.
go back to reference Gok G, Karadag M, Cinar T, Nurkalem Z, Duman D. In-hospital and short-term predictors of mortality in patients with intermediate-high risk pulmonary embolism. J Cardiovasc Thorac. 2020;12(4):321–7.CrossRef Gok G, Karadag M, Cinar T, Nurkalem Z, Duman D. In-hospital and short-term predictors of mortality in patients with intermediate-high risk pulmonary embolism. J Cardiovasc Thorac. 2020;12(4):321–7.CrossRef
28.
go back to reference Bohm M, Reil JC, Deedwania P, Kim JB, Borer JS. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med. 2015;128(3):219–28.PubMedCrossRef Bohm M, Reil JC, Deedwania P, Kim JB, Borer JS. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med. 2015;128(3):219–28.PubMedCrossRef
29.
go back to reference Chen Z, Pan W, Cao J, Dai X, Lin W, Chen H, Yi K, Yu M. Admission Heart Rate and Mortality in Critically Ill Patients with Acute Aortic Dissection. Int Heart J. 2023;64(1):44–52.PubMedCrossRef Chen Z, Pan W, Cao J, Dai X, Lin W, Chen H, Yi K, Yu M. Admission Heart Rate and Mortality in Critically Ill Patients with Acute Aortic Dissection. Int Heart J. 2023;64(1):44–52.PubMedCrossRef
30.
go back to reference Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, et al. Admission Heart Rate Is a Determinant of Effectiveness of Beta-Blockers in Acute Myocardial Infarction Patients. Circ J. 2019;83(5):1054–63.PubMedCrossRef Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, et al. Admission Heart Rate Is a Determinant of Effectiveness of Beta-Blockers in Acute Myocardial Infarction Patients. Circ J. 2019;83(5):1054–63.PubMedCrossRef
31.
go back to reference Mullerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, Bakke P, Agusti A, Anzueto A. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147(4):999–1007.PubMedCrossRef Mullerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, Bakke P, Agusti A, Anzueto A. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147(4):999–1007.PubMedCrossRef
32.
go back to reference Sogaard M, Madsen M, Lokke A, Hilberg O, Sorensen HT, Thomsen RW. Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia. Int J Chronic Obstr. 2016;11:455–65. Sogaard M, Madsen M, Lokke A, Hilberg O, Sorensen HT, Thomsen RW. Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia. Int J Chronic Obstr. 2016;11:455–65.
33.
go back to reference Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–6.PubMedCrossRef Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–6.PubMedCrossRef
34.
go back to reference Morasert T, Jantarapootirat M, Phinyo P, Patumanond J. Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study. Bmj Open Respir Res. 2020;7(1):e000488. Morasert T, Jantarapootirat M, Phinyo P, Patumanond J. Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study. Bmj Open Respir Res. 2020;7(1):e000488.
35.
go back to reference Sprooten R, Rohde G, Lawyer G, Leijte WT, Wouters E, Franssen F. Risk stratification for short-term mortality at hospital admission for acute exacerbations of COPD. Respirology. 2019;24(8):765–76.PubMedCrossRef Sprooten R, Rohde G, Lawyer G, Leijte WT, Wouters E, Franssen F. Risk stratification for short-term mortality at hospital admission for acute exacerbations of COPD. Respirology. 2019;24(8):765–76.PubMedCrossRef
36.
go back to reference Chen L, Chen L, Zheng H, Wu S, Wang S. The association of blood urea nitrogen levels upon emergency admission with mortality in acute exacerbation of chronic obstructive pulmonary disease. Chron Resp Dis. 2021;18:241482925.CrossRef Chen L, Chen L, Zheng H, Wu S, Wang S. The association of blood urea nitrogen levels upon emergency admission with mortality in acute exacerbation of chronic obstructive pulmonary disease. Chron Resp Dis. 2021;18:241482925.CrossRef
37.
go back to reference Ricci F, Wollmer P, Engstrom G, Fedorowski A, Hamrefors V. Markers of cardiovascular autonomic dysfunction predict COPD in middle-aged subjects. Eur Respir J. 2018;1(2):1702481. Ricci F, Wollmer P, Engstrom G, Fedorowski A, Hamrefors V. Markers of cardiovascular autonomic dysfunction predict COPD in middle-aged subjects. Eur Respir J. 2018;1(2):1702481.
38.
go back to reference Jensen MT, Marott JL, Lange P, Vestbo J, Schnohr P, Nielsen OW, Jensen JS, Jensen GB. Resting heart rate is a predictor of mortality in COPD. Eur Respir J. 2013;42(2):341–9.PubMedCrossRef Jensen MT, Marott JL, Lange P, Vestbo J, Schnohr P, Nielsen OW, Jensen JS, Jensen GB. Resting heart rate is a predictor of mortality in COPD. Eur Respir J. 2013;42(2):341–9.PubMedCrossRef
39.
go back to reference Middlekauff HR, Park J, Moheimani RS. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. J Am Coll Cardiol. 2014;64(16):1740–50.PubMedCrossRef Middlekauff HR, Park J, Moheimani RS. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. J Am Coll Cardiol. 2014;64(16):1740–50.PubMedCrossRef
40.
go back to reference Pan L, Dong W, Li H, Miller MR, Chen Y, Loh M, Wu S, Xu J, Yang X, Shima M, et al. Association patterns for size-fractioned indoor particulate matter and black carbon and autonomic function differ between patients with chronic obstructive pulmonary disease and their healthy spouses. Environ Pollut. 2018;236:40–8.PubMedCrossRef Pan L, Dong W, Li H, Miller MR, Chen Y, Loh M, Wu S, Xu J, Yang X, Shima M, et al. Association patterns for size-fractioned indoor particulate matter and black carbon and autonomic function differ between patients with chronic obstructive pulmonary disease and their healthy spouses. Environ Pollut. 2018;236:40–8.PubMedCrossRef
41.
go back to reference Lombardo TW, Epstein LH. The nicotine paradox: effect of smoking on autonomic discrimination. Addict Behav. 1986;11(3):341–4.PubMedCrossRef Lombardo TW, Epstein LH. The nicotine paradox: effect of smoking on autonomic discrimination. Addict Behav. 1986;11(3):341–4.PubMedCrossRef
42.
go back to reference Wang X, Jiang Z, Chen B, Zhou L, Kong Z, Zuo S, Liu H, Yin S. Cardiac autonomic function in patients with acute exacerbation of chronic obstructive pulmonary disease with and without ventricular tachycardia. BMC Pulm Med. 2016;16(1):124.PubMedPubMedCentralCrossRef Wang X, Jiang Z, Chen B, Zhou L, Kong Z, Zuo S, Liu H, Yin S. Cardiac autonomic function in patients with acute exacerbation of chronic obstructive pulmonary disease with and without ventricular tachycardia. BMC Pulm Med. 2016;16(1):124.PubMedPubMedCentralCrossRef
43.
go back to reference Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, Magnussen H. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010;138(1):32–8.PubMedCrossRef Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, Magnussen H. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010;138(1):32–8.PubMedCrossRef
44.
go back to reference Smith BM, Prince MR, Hoffman EA, Bluemke DA, Liu CY, Rabinowitz D, Hueper K, Parikh MA, Gomes AS, Michos ED, et al. Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study. Chest. 2013;144(4):1143–51.PubMedPubMedCentralCrossRef Smith BM, Prince MR, Hoffman EA, Bluemke DA, Liu CY, Rabinowitz D, Hueper K, Parikh MA, Gomes AS, Michos ED, et al. Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study. Chest. 2013;144(4):1143–51.PubMedPubMedCentralCrossRef
Metadata
Title
Association between admission heart rate and in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: a retrospective cohort study
Authors
Ruoqing Zhou
Dianzhu Pan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-02934-w

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine